|
ARWR | Arrowhead Pharmaceuticals, Inc. |
|
|
ARWR | Arrowhead Pharmaceuticals, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.14 |
| Leverage | 62.17% |
| Market Cap | $ 3.6B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -146.2m |
| Margin | -25.62% |
Arrowhead Pharmaceuticals, Inc. develops drugs for the treatment of intractable diseases in the United States. The company is headquartered in Pasadena, California.